Dermazor
Product Images NDC 63302-202

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dermazor (NDC 63302-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prestigio Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

02

Dermazor Psoriasis and Seborrheic Dermatitis Medicated Skin Treatment is a cream packaged in a 100 ml (3.5 FL OZ) container. The label highlights its patented formula containing 3% salicylic acid, zinc, and a cannabis oil complex. It is described as hypoallergenic, non-steroidal, non-coal tar, and dermatologist tested. The product is distributed by DISTR. MEDLIFE USA and made in Israel by Prestigio Ltd. The label includes drug facts, usage instructions, warnings, inactive ingredients, and claims such as relieving itching, redness, irritation, flaking, scaling, and dryness. It also features before-and-after images of treated skin, emphasizes safety for all skin types, and shows FDA OTC listing with NDC 63302-202.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.